Participating patients are generally required to have a good response to ART and reasonable levels of CD4+ T-cell counts (usually >200 cells/μl).15–17 However, few treatment strategies are designed to treat severely immunosuppressed AIDS patients with CD4+ T-cell counts <50 cells/μl. This evidence concerns the gene CD4 and AIDS.